<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4AD39D3C-7EEF-4BDC-B9A1-E743C28E6DEE"><gtr:id>4AD39D3C-7EEF-4BDC-B9A1-E743C28E6DEE</gtr:id><gtr:name>Royal Wolverhampton Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>New Cross Hospital</gtr:line1><gtr:line2>Wolverhampton Road</gtr:line2><gtr:postCode>WV10 0QP</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/340288BD-BCA1-46AA-BA5C-D85DDA0D29C8"><gtr:id>340288BD-BCA1-46AA-BA5C-D85DDA0D29C8</gtr:id><gtr:name>August Pi i Sunyer Biomedical Research Institute (IDIBAPS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8FE3A477-8A3B-4E51-AE01-4ABCE9099213"><gtr:id>8FE3A477-8A3B-4E51-AE01-4ABCE9099213</gtr:id><gtr:name>Cardiff Metropolitan University</gtr:name><gtr:address><gtr:line1>Llandaff Campus 200 Western Avenue</gtr:line1><gtr:line4>Caerdydd</gtr:line4><gtr:postCode>CF5 2YB</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0208630-810E-49A9-880C-7B9513417913"><gtr:id>C0208630-810E-49A9-880C-7B9513417913</gtr:id><gtr:name>Royal Institute of Technology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2962BD59-7137-499B-829A-DF39C00C47FD"><gtr:id>2962BD59-7137-499B-829A-DF39C00C47FD</gtr:id><gtr:name>Birmingham Community Healthcare NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/CAA9A40D-0226-4A4F-AC0D-D8299E30A1EF"><gtr:id>CAA9A40D-0226-4A4F-AC0D-D8299E30A1EF</gtr:id><gtr:name>Loughborough University</gtr:name><gtr:department>Chemical Engineering</gtr:department><gtr:address><gtr:line1>Loughborough University</gtr:line1><gtr:line4>Loughborough</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE11 3TU</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CAA9A40D-0226-4A4F-AC0D-D8299E30A1EF"><gtr:id>CAA9A40D-0226-4A4F-AC0D-D8299E30A1EF</gtr:id><gtr:name>Loughborough University</gtr:name><gtr:address><gtr:line1>Loughborough University</gtr:line1><gtr:line4>Loughborough</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE11 3TU</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4AD39D3C-7EEF-4BDC-B9A1-E743C28E6DEE"><gtr:id>4AD39D3C-7EEF-4BDC-B9A1-E743C28E6DEE</gtr:id><gtr:name>Royal Wolverhampton Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>New Cross Hospital</gtr:line1><gtr:line2>Wolverhampton Road</gtr:line2><gtr:postCode>WV10 0QP</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/340288BD-BCA1-46AA-BA5C-D85DDA0D29C8"><gtr:id>340288BD-BCA1-46AA-BA5C-D85DDA0D29C8</gtr:id><gtr:name>August Pi i Sunyer Biomedical Research Institute (IDIBAPS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8FE3A477-8A3B-4E51-AE01-4ABCE9099213"><gtr:id>8FE3A477-8A3B-4E51-AE01-4ABCE9099213</gtr:id><gtr:name>Cardiff Metropolitan University</gtr:name><gtr:address><gtr:line1>Llandaff Campus 200 Western Avenue</gtr:line1><gtr:line4>Caerdydd</gtr:line4><gtr:postCode>CF5 2YB</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0208630-810E-49A9-880C-7B9513417913"><gtr:id>C0208630-810E-49A9-880C-7B9513417913</gtr:id><gtr:name>Royal Institute of Technology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2962BD59-7137-499B-829A-DF39C00C47FD"><gtr:id>2962BD59-7137-499B-829A-DF39C00C47FD</gtr:id><gtr:name>Birmingham Community Healthcare NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/66C3E435-C79D-47F1-9A3C-22546461803D"><gtr:id>66C3E435-C79D-47F1-9A3C-22546461803D</gtr:id><gtr:name>Assoc of British Healthcare Industries</gtr:name><gtr:address><gtr:line1>Industries</gtr:line1><gtr:line2>250 Waterloo Road</gtr:line2><gtr:postCode>SE1 8RD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/253B8585-2AC5-4802-95A4-6A4171EA10D0"><gtr:id>253B8585-2AC5-4802-95A4-6A4171EA10D0</gtr:id><gtr:name>Hygiene Solutions</gtr:name><gtr:address><gtr:line1>8 Pool Road Industrial Estate</gtr:line1><gtr:postCode>CV10 9AE</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B0F4FC88-7CA8-4211-BC3A-EB468C342DDF"><gtr:id>B0F4FC88-7CA8-4211-BC3A-EB468C342DDF</gtr:id><gtr:name>Collegium Basilea</gtr:name><gtr:address><gtr:line1>Hochstrasse 51</gtr:line1><gtr:postCode>4053</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0CEB76FA-920C-4ABF-BD53-058AA5F4802D"><gtr:id>0CEB76FA-920C-4ABF-BD53-058AA5F4802D</gtr:id><gtr:name>University Hospitals of Leicester NHS</gtr:name><gtr:address><gtr:line1>Leicester Royal Infirmary</gtr:line1><gtr:line2>Infirmary Square</gtr:line2><gtr:postCode>LE1 5WW</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C8D4C8E2-E8EA-4551-85BA-16C4F523B91E"><gtr:id>C8D4C8E2-E8EA-4551-85BA-16C4F523B91E</gtr:id><gtr:name>Infection Prevention Society (IPS)</gtr:name><gtr:address><gtr:line1>Blackburn House</gtr:line1><gtr:line2>Redhouse Road</gtr:line2><gtr:postCode>EH47 7AQ</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/645E3985-BCD4-4DB2-939B-78D77DC00711"><gtr:id>645E3985-BCD4-4DB2-939B-78D77DC00711</gtr:id><gtr:name>Southport &amp; Ormskirk Hospital NHS Trust</gtr:name><gtr:address><gtr:line1>Town Lane</gtr:line1><gtr:line2>Kew</gtr:line2><gtr:postCode>PR8 6PN</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3D4B099E-7B6C-4422-9E1E-0D60E662E875"><gtr:id>3D4B099E-7B6C-4422-9E1E-0D60E662E875</gtr:id><gtr:name>Smith &amp; Nephew Medical Ltd</gtr:name><gtr:address><gtr:line1>PO Box 81</gtr:line1><gtr:line2>Hessle Road</gtr:line2><gtr:postCode>HU3 2BN</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CA614C8D-AE60-4F15-8E9C-FB35499963EF"><gtr:id>CA614C8D-AE60-4F15-8E9C-FB35499963EF</gtr:id><gtr:name>NHS Lanarkshire</gtr:name><gtr:address><gtr:line1>Hairmyres Hospital</gtr:line1><gtr:line2>Eaglesham Road</gtr:line2><gtr:postCode>G75 8RG</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/41D31E28-5F40-43AB-A1A2-901906C757A4"><gtr:id>41D31E28-5F40-43AB-A1A2-901906C757A4</gtr:id><gtr:name>EMIDRN</gtr:name><gtr:address><gtr:line1>Dept of Clinical Microbiology</gtr:line1><gtr:line2>QMC Campus</gtr:line2><gtr:line3>Derby Road</gtr:line3><gtr:postCode>NG7 2UH</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/680544C9-27A4-477E-8CAD-EB8F01D10F63"><gtr:id>680544C9-27A4-477E-8CAD-EB8F01D10F63</gtr:id><gtr:firstName>Emily</gtr:firstName><gtr:surname>Rousham</gtr:surname><gtr:orcidId>0000-0001-5654-9279</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/775605A9-2D71-4B73-BA4B-2E1A24B580C9"><gtr:id>775605A9-2D71-4B73-BA4B-2E1A24B580C9</gtr:id><gtr:firstName>Danish</gtr:firstName><gtr:otherNames>Javed</gtr:otherNames><gtr:surname>Malik</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/663095BA-6CC1-4DF9-B8DB-260727D03B61"><gtr:id>663095BA-6CC1-4DF9-B8DB-260727D03B61</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Peter</gtr:otherNames><gtr:surname>Ward</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BDA53D31-4FEE-4A58-8B4B-DACBCE52E2EC"><gtr:id>BDA53D31-4FEE-4A58-8B4B-DACBCE52E2EC</gtr:id><gtr:firstName>Sourav</gtr:firstName><gtr:surname>Ghosh</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3DD4FE68-C541-440B-BD1A-0EBD21E4FB1C"><gtr:id>3DD4FE68-C541-440B-BD1A-0EBD21E4FB1C</gtr:id><gtr:firstName>Marc</gtr:firstName><gtr:otherNames>Colin</gtr:otherNames><gtr:surname>Kimber</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FM027341%2F1"><gtr:id>D1C97D9E-9C13-4A12-9E27-4D8B584970A6</gtr:id><gtr:title>Tackling Antimicrobial Resistance: An Interdisciplinary Approach</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/M027341/1</gtr:grantReference><gtr:abstractText>The proposal aims to facilitate and encourage multidisciplinary research at Loughborough University (LU) into the healthcare environment (air, water and surfaces) and in community settings (e.g. nursing and care homes, low income countries with high population densities) as potential reservoirs for the transmission of antimicrobial resistant infectious agents. Hospital surfaces are a reservoir for transmission of antimicrobial resistant infectious agents, typically via contamination of the hands of healthcare workers. Staphylococci, C. difficile and Acinetobacter species have been shown to survive many months on high touch near-patient surfaces in healthcare environments. Recent epidemiological evidence suggests that patients admitted to rooms previously occupied by colonised patients have a higher probability of acquiring (i.e. is a risk factor for colonisation or infection) the same pathogen. Other studies have shown aerial dissemination of infectious agents, e.g. C. difficile spores, making it particularly difficult to eradicate infectious agents in hospitals. Despite a recent focus on performance management to improve the efficacy of cleaning and disinfection processes, published studies have demonstrated the presence of culturable indicator organisms (e.g. Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant enterococci) post conventional &amp;quot;terminal disinfection&amp;quot; (i.e. upon patient discharge). Bacterial endospores (e.g. Clostridium difficile) are particularly resilient to routine disinfection treatments due to a variety of factors including use of insufficient, low concentration disinfectant, inadequate contact times etc .The Chief Medical Officer's report highlights issues such as poor design that limits cleaning, poor ventilation and poor water-supply management (risk of Legionella species and Pseudomonas aeruginosa). One of the problems of AMR is the length of time taken to identify pathogens (1-3 days) resulting in (i) potential spread of infectious agents; (ii) antibiotics given to patients unnecessarily 'just in case'. Rapid diagnostics would aid early detection and isolation of patients that would otherwise spread contamination. Photocatalytic self-cleaning surfaces could inactivate infectious agents landing on surfaces thereby breaking the link between contaminated surfaces and transmission through contact. Barriers and levers could be identified to improve hand-hygiene compliance whilst monitoring compliance in real-time using teletracking technology. Novel surface, air and water disinfection systems could be developed e.g. using atmospheric plasma technology. Natural ventilation systems could be designed to improve air quality and reduce dispersal of infectious agents in multi-bed wards. The proposal aims to focus on the following three AMR research themes: (i) Accelerating therapeutic and diagnostics development - Alternative approaches to treat resistant bacteria; New technologies for identifying resistant bacteria to underpin diagnostics development; Scale-up and manufacture of biotherapeutics; The effective delivery of existing antimicrobial agents (ii) Understanding the real world interactions - Understanding the role of the environment as a reservoir for AMR microorganisms and the transmission of infections in community and healthcare environments; Ways to manipulate the environment to prevent transmission (iii) Behaviour within and beyond the healthcare setting - Elucidate underpinning motivations for human behaviours relating to the spread of AMR infectious microorganisms in the healthcare environment and the community; Evaluate interventions to control/prevent the spread of resistant bacteria.</gtr:abstractText><gtr:potentialImpactText>The proposed Bridging the Gaps bid aims to bring together highly relevant broad academic expertise in the identified AMR research themes : the focus of the project will be on the environment in healthcare and the community, as a reservoir for the transmission of infections. Through cross-sector engagement multidisciplinary research teams will focus on solving clinically-relevant problems. Strong involvement of clinical partners will ensure critical oversight of problem definition so that the ideas that receive funding have the potential to address real-world problems. Problem-led research will be fed through to clinical partners to work jointly on implementation and behaviour change within healthcare organisations. The potential for policy change within public health will be addressed through collaboration with national organisations (e.g. Public Health England). The programme will have strong clinical and industrial steer using its advisory board chaired by Peter Ellingworth (CEO, ABHI) with high level representatives drawn from the NHS (e.g. The Royal Wolverhampton NHS Trust, University Hospitals of Leicester NHS Trust), Charities (e.g. Infection Prevention Society), regional bodies (e.g. East Midlands Infectious Diseases Research Network, EMIDRN) and Industry (e.g. Smith &amp;amp; Nephew, Hygiene Solutions etc). Industrial partners supporting the project will bring a commercial edge to the activities to ensure opportunities for commercialisation are not overlooked. There will be considerable potential for development of new Intellectual Property around innovative technologies, equipment and techniques, and the added benefit of developing these innovations from a multidisciplinary perspective focusing on AMR. The LU Enterprise Office will be engaged at an early stage in the AMR BtG activities to help facilitate knowledge transfer e.g. through 'Innovate UK' funded 'knowledge transfer partnerships', and with intellectual property protection (e.g. early exploration of intellectual property potential of new research ideas through patent applications). The Advisory/Management Group will ensure continued benefit and impact by representing the voices of all stakeholders and guiding the research, as well as providing a path to addressing problems facing healthcare providers in particular. The network will be further developed using the already established network of contacts of the collaborating organisations and their members e.g. leveraging Medilink (EMIDRN), Infection Prevention Society (IPS), ABHI and targeting other related networks e.g. Hospital Infection Society (HIS).</gtr:potentialImpactText><gtr:fund><gtr:end>2018-01-08</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2015-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>545919</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>To characterize the volatile metabolites for bio-profiling infecting organisms in chronic wounds</gtr:description><gtr:id>6B3AF5BB-CFF3-42AC-BC28-0277385B2F6E</gtr:id><gtr:impact>Recent collaboration still ongoing. Outputs will arise in 12 months time.

Project is multidisciplinary involving analytical sciences, microbiology and wound specialists.</gtr:impact><gtr:outcomeId>58c7cf0a967e00.62602100-2</gtr:outcomeId><gtr:partnerContribution>Expertise in wound microbiology and clinical chronic wound management and surgical treatment.</gtr:partnerContribution><gtr:piContribution>Loughborough has expertise in the field Volatiles profiling using mass spectrometry. This expertise is being used to identify volatile signatures arising from bacteria colonisation and infection in wounds.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Wolverhampton Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Renal Unit</gtr:department><gtr:description>Collaborative partnership with two NHS Trusts, for proof-of-concept study title 'Reducing misdiagnosis and antibiotic prescribing practices in hospitals: a case series review and qualitative study of diagnosis, management and treatment of urinary tract infections in adults aged over 70 years'</gtr:description><gtr:id>8A284959-3C96-4E7E-92EA-2FB8F0CED364</gtr:id><gtr:impact>Data collection started in November 2016 and is still ongoing. The collaboration is multidiscplinary with epidemiologists, social scientists, microbiologists and physicians.</gtr:impact><gtr:outcomeId>5888bd93458569.11292995-2</gtr:outcomeId><gtr:partnerContribution>Birmingham Community Healthcare NHS Trust have acted as study sponsor, and this is a multi-site study. At each of the two NHS Trust sites, a consultant microbiology is on the research team. The consultant microbiologist at BCHC is the PI for the purposes of the NHS protocol. Through BCHC NHS Trust, we have employed a NIHR network clinical research nurse to work on the study.</gtr:partnerContribution><gtr:piContribution>I am PI for the proof of concept study (&amp;pound;25,000 award through the EPSRC Tackling Antimicrobial Resistance Award), and study coordinator in the NHS protocol. I took responsibility for designing the study, submitting the application for NHS ethics approval and involving Patient Public Involvement Groups.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>August Pi i Sunyer Biomedical Research Institute (IDIBAPS)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Hospital Clinic of Barcelona</gtr:department><gtr:description>To characterize the volatile metabolites produced by strains of Pseudomonas aeruginosa</gtr:description><gtr:id>028C0358-78B2-49F0-AB33-ED58FD03882A</gtr:id><gtr:impact>No outputs as yet as project has recently started. Project is multidisciplinary involving analytical sciences, immunology and clinical expertise in pneumonia.</gtr:impact><gtr:outcomeId>58c7d067d916e8.76924356-2</gtr:outcomeId><gtr:partnerContribution>Expertise in host infection and inflammation biomarkers and clinical expertise related to pneumonia.</gtr:partnerContribution><gtr:piContribution>Loughborough brings expertise in analytical sciences related to measuring volatiles in exhaled breath using mass spectrometry.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff Metropolitan University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Heath Sciences</gtr:department><gtr:description>To characterize the volatile metabolites for bio-profiling infecting organisms in chronic wounds</gtr:description><gtr:id>BEB4EB95-4C99-46D5-AA7F-66DB6EC00504</gtr:id><gtr:impact>Recent collaboration still ongoing. Outputs will arise in 12 months time.

Project is multidisciplinary involving analytical sciences, microbiology and wound specialists.</gtr:impact><gtr:outcomeId>58c7cf0a967e00.62602100-1</gtr:outcomeId><gtr:partnerContribution>Expertise in wound microbiology and clinical chronic wound management and surgical treatment.</gtr:partnerContribution><gtr:piContribution>Loughborough has expertise in the field Volatiles profiling using mass spectrometry. This expertise is being used to identify volatile signatures arising from bacteria colonisation and infection in wounds.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>To characterize the volatile metabolites produced by strains of Pseudomonas aeruginosa</gtr:description><gtr:id>61A370B5-4391-4BB4-9C79-305F3D69E024</gtr:id><gtr:impact>No outputs as yet as project has recently started. Project is multidisciplinary involving analytical sciences, immunology and clinical expertise in pneumonia.</gtr:impact><gtr:outcomeId>58c7d067d916e8.76924356-1</gtr:outcomeId><gtr:partnerContribution>Expertise in host infection and inflammation biomarkers and clinical expertise related to pneumonia.</gtr:partnerContribution><gtr:piContribution>Loughborough brings expertise in analytical sciences related to measuring volatiles in exhaled breath using mass spectrometry.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Birmingham Community Healthcare NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaborative partnership with two NHS Trusts, for proof-of-concept study title 'Reducing misdiagnosis and antibiotic prescribing practices in hospitals: a case series review and qualitative study of diagnosis, management and treatment of urinary tract infections in adults aged over 70 years'</gtr:description><gtr:id>2C65897C-0F87-4434-9830-924B0BCD0789</gtr:id><gtr:impact>Data collection started in November 2016 and is still ongoing. The collaboration is multidiscplinary with epidemiologists, social scientists, microbiologists and physicians.</gtr:impact><gtr:outcomeId>5888bd93458569.11292995-1</gtr:outcomeId><gtr:partnerContribution>Birmingham Community Healthcare NHS Trust have acted as study sponsor, and this is a multi-site study. At each of the two NHS Trust sites, a consultant microbiology is on the research team. The consultant microbiologist at BCHC is the PI for the purposes of the NHS protocol. Through BCHC NHS Trust, we have employed a NIHR network clinical research nurse to work on the study.</gtr:partnerContribution><gtr:piContribution>I am PI for the proof of concept study (&amp;pound;25,000 award through the EPSRC Tackling Antimicrobial Resistance Award), and study coordinator in the NHS protocol. I took responsibility for designing the study, submitting the application for NHS ethics approval and involving Patient Public Involvement Groups.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Institute of Technology</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Clinical Microfluidics Laboratory</gtr:department><gtr:description>Isolation and analysis of bacteria from whole blood for rapid sepsis diagnostics</gtr:description><gtr:id>2134B1B9-12E6-495A-B83A-7ADD99F26ACE</gtr:id><gtr:impact>Project is currently underway - outputs will arise in 12 months time. This project is multidisciplinary.

Dr Sourav Ghosh, Lecturer in Healthcare Engineering, Loughborough University: an acoustic sensor expert, who will lead the overall project and the ADT sensor development.

Dr Aman Russom#, Associate Professor and Head of the Clinical Microfluidics lab at KTH Royal Institute of Technology, Stockholm: a clinical sample processing expert, who will lead the selective cell lysis work.

Dr Volkan &amp;Ouml;zenci#, Senior Consultant and Associate Professor, Division of Clinical Microbiology, Karolinska University Hospital, Stockholm: a clinical microbiology expert, who will provide the clinical supervision in the project and host the researcher for the clinical work.</gtr:impact><gtr:outcomeId>58c7cb9c3d10b7.34831860-1</gtr:outcomeId><gtr:partnerContribution>Dr Aman Russom's group at KTH Royal Institute of Technology, Sweden, has demonstrated selective cell lysis of whole blood cells which is key to the coupling of the microfluidic blood handling part of the project and the detection.</gtr:partnerContribution><gtr:piContribution>Loughborough academics have expertise in label-free nonlinear acoustic detection technique which is being used in this collaborative project for the analysis of bacteria from whole blood for rapid sepsis diagnosis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cardiovascular Sciences</gtr:department><gtr:description>A novel platform for rapid and direct detection of diarrheagenic pathogen combining nonlinear acoustic technique with molecular imprinted polymer</gtr:description><gtr:id>CA5EBE49-6693-4EFB-B7BF-78B77B054B06</gtr:id><gtr:impact>Project is currently underway, outputs will arise over the next 12 months. The project is multidisciplinary. The disciplines are Mechanical Engineering and Polymer Chemistry.</gtr:impact><gtr:outcomeId>58c7cd24ad3b40.84295576-1</gtr:outcomeId><gtr:partnerContribution>Professor Sergey Piletsky (University of Leicester) is a leading expert in the synthesis of molecular imprinted polymers which are being developed to sense bacterial and viral epitopes.</gtr:partnerContribution><gtr:piContribution>Loughborough academic (Dr. Sourav Ghosh) has expertise in anharmonic (nonlinear) acoustic technique which is being used to develop a novel platform for rapid and direct detection of diarrheagenic pathogens</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Consultation with Patient Public Involvement Group</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>39A59E6E-5422-4A48-AB36-D4705DDC2B83</gtr:id><gtr:impact>The research team and a representative from our study sponsor attended the Leicestershire and Rutland Frail and Older Adults Patient, Public Involvement group. We wanted to discuss the acceptability of our proposed research design, and we also asked for the opinion of the group about a particular issue surrounding ethics. Following feedback from the group, we modified some of the language in our recruitment materials for the study, we also made some important notes about the concerns of the group regarding ethical procedures, and these went into the considerations of our proposal submitted to the NHS Health Research Authority. We found the engagement with the group very valuable.</gtr:impact><gtr:outcomeId>58bc32d7d61cc4.08390101</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wound &amp; Biofilms Workshop 13 &amp; 14 December 2016, Loughborough University</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>53DE987C-6B6E-474B-8F86-942B82BEA607</gtr:id><gtr:impact>Workshop focused on specific clinical theme (wounds and biofilms) to identify clinical needs and opportunities where Loughborough with its partners could make impact. The workshop resulted in building of Interdisciplinary research teams around specific project ideas developed in workshops to address specific challenges within the clinical theme where we are best placed to make significant impact. We have successfully encouraged early career researchers to engage with the AMR research challenges by inviting them to workshops and encouraging them to take on roles as project leads. Workshops have included 'clinical problem champions' with strong support from our 'Advisory Board' to help the network better understand specific AMR challenges that we as an organisation can engage with but also to impress upon the network the national and global importance of these challenges. We have reached out to international external collaborators with a view to positioning our network to target funding through the Global Challenges Research Fund (GCRF); this will allow us to extend further research supported through the AMR network working in partnership with international institutions.</gtr:impact><gtr:outcomeId>58c7d2175976f4.32316868</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Diagnostics Workshop, 21st June 2016, Loughborough University</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A4CC8DA6-00B7-4BAF-AEE4-3C9DC3027F0A</gtr:id><gtr:impact>Workshop focused on specific clinical theme (diagnostics) to identify clinical needs and opportunities where Loughborough with its partners could make impact. The workshop resulted in building of Interdisciplinary research teams around specific project ideas developed in workshops to address specific challenges within the clinical theme where we are best placed to make significant impact. We have successfully encouraged early career researchers to engage with the AMR research challenges by inviting them to workshops and encouraging them to take on roles as project leads. Workshops have included 'clinical problem champions' with strong support from our 'Advisory Board' to help the network better understand specific AMR challenges that we as an organisation can engage with but also to impress upon the network the national and global importance of these challenges. We have reached out to international external collaborators with a view to positioning our network to target funding through the Global Challenges Research Fund (GCRF); this will allow us to extend further research supported through the AMR network working in partnership with international institutions.</gtr:impact><gtr:outcomeId>58c7d2982368b6.10396325</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AMR Workshop Hosted at Loughborough</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>564D31DA-C06A-45D8-AEFA-B91CE1E4040D</gtr:id><gtr:impact>Engaging interdisciplinary researchers/clinicians/industry/policy makers to map needs and challenges associated with AMR. Mapped clinical need and identified potential research projects to address this need. Held a series of invited seminars for clinicians and industry relevant to AMR.</gtr:impact><gtr:outcomeId>56e037f57afeb6.27577880</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.lboro.ac.uk/research/amr/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>122A55ED-A50D-49F0-988F-D65B7398DC99</gtr:id><gtr:title>Detection of flexibly bound adsorbate using the nonlinear response of quartz crystal resonator driven at high oscillation amplitude</gtr:title><gtr:parentPublicationTitle>Electrochimica Acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8c2be9964dc0dedae1263c6be625624"><gtr:id>f8c2be9964dc0dedae1263c6be625624</gtr:id><gtr:otherNames>Khobragade S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aa68f230b6ec8.89811531</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13B92AAA-69BD-4501-91C6-1816978ED9CD</gtr:id><gtr:title>Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.</gtr:title><gtr:parentPublicationTitle>Advances in colloid and interface science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e13e7cb0db442708185ace5d34297ea"><gtr:id>4e13e7cb0db442708185ace5d34297ea</gtr:id><gtr:otherNames>Malik DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0001-8686</gtr:issn><gtr:outcomeId>5a352d06b14876.60130405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A26D695D-3464-4EE2-9087-7470C9456538</gtr:id><gtr:title>Microencapsulation of Clostridium difficile specific bacteriophages using microfluidic glass capillary devices for colon delivery using pH triggered release.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a73fb23d16fe3f72184a19241b6c00a3"><gtr:id>a73fb23d16fe3f72184a19241b6c00a3</gtr:id><gtr:otherNames>Vinner GK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a2fef8851f530.59254159</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3221C3E4-4EB3-482E-A842-C04B5FC54610</gtr:id><gtr:title>Photoredox Approach to N-Acyl-N'-aryl-N,N'-aminals Using Enamides and Their Conversion to ?-Lactams.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b0fdd9c572559bfae12ad306cd59cb4"><gtr:id>0b0fdd9c572559bfae12ad306cd59cb4</gtr:id><gtr:otherNames>Koleoso OK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>5a995a9c1bfd84.99614877</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/M027341/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>E48C802F-8897-4353-910A-09D09331BB82</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Medical science &amp; disease</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>